Glazer Capital LLC’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Glazer Capital LLC’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,363,903	Closed	-$13.6M	–	761
2022 Q3	$13.6M	Buy	1,363,903 +551,221	+68%	+$5.47M	0.25%	128
2022 Q2	$8.02M	Buy	812,682 +691,654	+571%	+$6.82M	0.2%	169
2022 Q1	$1.19M	Buy	121,028 +1,915	+2%	+$18.8K	0.03%	298
2021 Q4	$1.16M	Buy	119,113 +113,985	+2,223%	+$1.12M	0.03%	386
2021 Q3	$50K	Buy	+5,128	New	+$50.1K	﹤0.01%	815

Glazer Capital LLC's FLAC Position: Q4 2022 in Review

Glazer Capital LLC sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 1,363,903 shares — an estimated $13.6M sold.

Glazer Capital LLC first reported a position in FLAC in Q3 2021 and held it in 5 quarters. The position peaked at $13.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Glazer Capital LLC reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 1,363,903 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $13.6M.
Glazer Capital LLC first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q3 2021 and held it in 5 quarters.
Glazer Capital LLC's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $13.6M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.